With a bunch of gene therapy and gene editing programs in clinical trials, CRISPR Therapeutics (NASDAQ: CRSP) has an ...

The global gene editing market is expected to reach USD 7.59 billion in 2029 from USD 4.66 billion in 2024, at a CAGR of 10.2 ...

Ethicists often debate how to understand reasonable risk. But it is widely agreed that reasonable risks must be minimised to ...

Understanding how human neurons cope with the energy demands of a large, active brain could open up new avenues for treating ...

Is the future of finance already written in the DNA of today's emerging technologies? Cathie Wood, CEO and CIO of Ark Invest, ...

Can we really achieve immortality? Explore the latest scientific breakthroughs, ethical dilemmas, and what the future might ...

On the wall of Dian Yang's office hangs a painting of a "Pandora's box of cancer" being opened with a molecular key. From ...

A biotech startup’s journey to unicorn status hinges on its leadership and the culture fostered within the organization. A ...

In a report released today, Robert Burns from H.C. Wainwright reiterated a Buy rating on Caribou Biosciences (CRBU – Research Report), ...

A virologist named Beata Halassy recently made headlines after publishing a report of successfully treating her own breast ...

Shoreline Biosciences, Inc., a biopharmaceutical company developing disease modifying iNK cell therapies for autoimmune ...